![Cillian King](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cillian King
Gründer bei
Koala Life Sciences BV
Profil
Dr. Cillian King is a Partner at EQT Life Sciences Group BV and a Founder at Koala Life Sciences BV.
He is on the Board of Directors at Sairopa B V, Muna Therapeutics ApS and QurAlis Corp.
Dr. King was previously employed as a Chairman-Supervisory Board by Allero Therapeutics BV and an Investment Manager by Swanbridge Capital Management BV.
He received his doctorate degree from Vrije Universiteit Amsterdam.
Aktive Positionen von Cillian King
| Unternehmen | Position | Beginn |
|---|---|---|
Muna Therapeutics ApS
 Muna Therapeutics ApS BiotechnologyHealth Technology Engages in discovering and developing of therapies that slow and stop devastating neurodegenerative, alzheimer’s & parkinson’s diseases | Direktor/Vorstandsmitglied | - |
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million. | Private Equity Investor | 01.01.2021 |
Koala Life Sciences BV | Gründer | 01.01.2017 |
QurAlis Corp.
 QurAlis Corp. Pharmaceuticals: MajorHealth Technology Develops precision medications | Direktor/Vorstandsmitglied | - |
Sairopa B V
 Sairopa B V MiscellaneousMiscellaneous Develops medicines and functions as an investment holding company | Direktor/Vorstandsmitglied | 01.01.2021 |
Ehemalige bekannte Positionen von Cillian King
| Unternehmen | Position | Ende |
|---|---|---|
Swanbridge Capital Management BV
 Swanbridge Capital Management BV Investment ManagersFinance Swanbridge Capital invests in Life Sciences companies located in the Rotterdam Science Tower we are in the very heart of the Life Sciences startup eco-system. The firm invests in early stage companies. | Private Equity Investor | 01.01.2021 |
Allero Therapeutics BV
 Allero Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Develops immunotherapy treatment for allergic and autoimmune diseases | Vorsitzender | 01.01.2021 |
Ausbildung von Cillian King
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
18
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
LSP Management Group BV
LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million. | Finance |
Vrije Universiteit Amsterdam
 Vrije Universiteit Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swanbridge Capital Management BV
Swanbridge Capital Management BV Investment ManagersFinance Swanbridge Capital invests in Life Sciences companies located in the Rotterdam Science Tower we are in the very heart of the Life Sciences startup eco-system. The firm invests in early stage companies. | Finance |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology Develops precision medications | Health Technology |
Allero Therapeutics BV
Allero Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Develops immunotherapy treatment for allergic and autoimmune diseases | Commercial Services |
Muna Therapeutics ApS
Muna Therapeutics ApS BiotechnologyHealth Technology Engages in discovering and developing of therapies that slow and stop devastating neurodegenerative, alzheimer’s & parkinson’s diseases | Health Technology |
Koala Life Sciences BV | |
Sairopa B V
Sairopa B V MiscellaneousMiscellaneous Develops medicines and functions as an investment holding company | Miscellaneous |
